Inventor
BRITTAIN HARRY G
US27 patents
⚠️ This page may combine multiple inventors who share the name “BRITTAIN HARRY G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THEAPRIN PHARMACEUTICALS INC
8 patentsUS9603937B2Mar 28, 2017
Platform drug delivery system utilizing crystal engineering and theanine dissolution
THEAPRIN PHARMACEUTICALS INC6 citations82
US12268783B2Apr 8, 2025
Platform drug delivery system utilizing crystal engineering and theanine dissolution
THEAPRIN PHARMACEUTICALS INC1 citations73
US9603939B2Mar 28, 2017
Platform drug delivery system utilizing crystal engineering and theanine dissolution
THEAPRIN PHARMACEUTICALS INC3 citations71
US9603938B2Mar 28, 2017
Platform drug delivery system utilizing crystal engineering and theanine dissolution
THEAPRIN PHARMACEUTICALS INC3 citations71
US9289440B2Mar 22, 2016
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
THEAPRIN PHARMACEUTICALS INC2 citations61
US8685948B2Apr 1, 2014
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
THEAPRIN PHARMACEUTICALS INC2 citations54
US10376464B2Aug 13, 2019
Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine
THEAPRIN PHARMACEUTICALS INC0 citations51
US9896411B2Feb 20, 2018
Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine
THEAPRIN PHARMACEUTICALS INC0 citations51
ALKERMES PHARMA IRELAND LTD
6 patentsUS10166228B2Jan 1, 2019
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD2 citations84
US9556189B2Jan 31, 2017
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD1 citations63
US10328070B1Jun 25, 2019
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD0 citations52
US9980958B2May 29, 2018
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD0 citations52
US9827240B2Nov 28, 2017
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD0 citations52
US9365580B2Jun 14, 2016
Polymorphic forms of naltrexone
ALKERMES PHARMA IRELAND LTD0 citations52
BRITTAIN HARRY G
5 patentsUS8173625B2May 8, 2012
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
BRITTAIN HARRY G32 citations94
US8304404B2Nov 6, 2012
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
BRITTAIN HARRY G10 citations91
US8389540B2Mar 5, 2013
Polymorphic forms of naltrexone
BRITTAIN HARRY G1 citations62
US9289439B2Mar 22, 2016
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
BRITTAIN HARRY G2 citations61
US9289438B2Mar 22, 2016
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
BRITTAIN HARRY G2 citations61
ALKERMES INC
4 patentsUS8975272B2Mar 10, 2015
Polymorphic forms of naltrexone
ALKERMES INC2 citations74
US7279579B2Oct 9, 2007
Polymorphic forms of naltrexone
ALKERMES INC4 citations71
US8735420B2May 27, 2014
Polymorphic forms of naltrexone
ALKERMES INC1 citations63
US9221830B2Dec 29, 2015
Polymorphic forms of naltrexone
ALKERMES INC0 citations52